Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001012975-16-001318
Filing Date
2016-06-23
Accepted
2016-06-23 21:24:50
Documents
1
Period of Report
2016-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5709
  Complete submission text file 0001012975-16-001318.txt   7748
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE - SUITE 3502 NEW YORK NY 10036
Business Address
Ratcliffe Liam (Reporting) CIK: 0001547100 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 161729726

Mailing Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036
Business Address C/O NEW LEAF VENTURE PARTNERS 7 TIMES SQUARE, SUITE 3502 NEW YORK NY 10036 646-871-6400
New Leaf Venture Partners, L.L.C. (Reporting) CIK: 0001631614 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 161729725